blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1214942

EP1214942 - Use of dendritic cells, loaded with bacteriophages which carry a tumour-specific and/or tumour-associated antigen on their surface, for treatment of tumours [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.05.2006
Database last updated on 05.10.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Apalexo Biotechnologie GmbH
Fraunhoferstrasse 18b
82152 Planegg/Martinsried / DE
[2003/17]
Former [2003/14]For all designated states
Apalexo Biotechnologie GmbH
Am Klopferspitz 19
82152 Planegg/Martinsried / DE
Former [2002/25]For all designated states
Immunogenec Biotechnologie GmbH
Am Klopferspitz 19
82152 Planegg/Martinsried / DE
Inventor(s)01 / Rohnisch, Tim
Stiftsbogen, 57
81375 Munchen / DE
02 / Pachmann, Katharina
Brandenburgerstrasse, 30
95448 Bayreuth / DE
 [2002/38]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2002/25]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date02003333.817.05.1999
[2002/25]
Priority number, dateDE199812192515.05.1998         Original published format: DE 19821925
WO1999EP0335314.05.1999         Original published format: PCT/EP99/03353
[2002/25]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP1214942
Date:19.06.2002
Language:DE
[2002/25]
Type: A3 Search report 
No.:EP1214942
Date:02.10.2002
[2002/40]
Search report(s)(Supplementary) European search report - dispatched on:EP16.08.2002
ClassificationIPC:A61K39/00, A61K39/385, A61P35/00, A61P37/04
[2002/25]
CPC:
C40B40/02 (EP); A61P35/00 (EP); A61P37/04 (EP);
C12N15/1037 (EP); A61K2039/53 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2003/26]
Former [2002/25]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE 
TitleGerman:Verwendung von mit Bacteriophagen, die ein tumorspezifisches und/oder tumorassoziliertes Antigen auf ihrer Oberfläche tragen, beladenen dendritischen Zellen zur Behandlung von Tumoren[2002/25]
English:Use of dendritic cells, loaded with bacteriophages which carry a tumour-specific and/or tumour-associated antigen on their surface, for treatment of tumours[2002/25]
French:Utilisation de cellules dendritiques, chargées avec des bactériophages qui portent à leur surface un antigène spécifique et/ou associé à une tumeur, pour le traitement de tumeurs[2002/25]
Examination procedure31.10.2002Examination requested  [2003/01]
03.09.2003Despatch of a communication from the examining division (Time limit: M06)
11.03.2004Reply to a communication from the examining division
01.12.2005Application deemed to be withdrawn, date of legal effect  [2006/23]
04.01.2006Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2006/23]
Parent application(s)   TooltipEP99924991.5  / EP1077720
Fees paidRenewal fee
12.03.2002Renewal fee patent year 03
12.03.2002Renewal fee patent year 04
30.05.2003Renewal fee patent year 05
28.05.2004Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.05.200507   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]WO9207077  (PERHAM RICHARD NELSON [GB], et al) [YD] 1,2,4,5,7-9 * page 4, line 33 - page 6, line 10 * * page 8, line 8 - line 22 * * page 19, line 32 - page 20, line 37 * * claims 1-9 *;
 [A]WO9531107  (UNIV ILLINOIS [US]) [A] 1-9 * page 4, line 1 - line 9 * * page 8, line 5 - page 9, line 5 * * examples 4,5,11 * * claims 1-9 *;
 [A]US5674486  (SOBOL ROBERT E [US], et al) [A] 1-9 * column 2, line 55 - column 3, line 2 * * column 3, line 38 - line 51 * * column 3, line 64 - column 4, line 8 * * column 4, line 59 - column 5, line 32 ** claims 1-12,19-21,25-36,42,43 *;
 [Y]  - ROEHNISCH T ET AL, "DEVELOPMENT OF LYMPHOMASPECIFIC IDIOTYPE VACCINE FOR INDUCTION OF A SPECIFIC CYTOTOXIC IMMUNE RESPONSE", ANNALS OF HEMATOLOGY, BERLIN, DE, (1996), vol. 73, no. SUPPL 2, ISSN 0939-5555, page A154, XP000857050 [Y] 1,2,4,5,7-9 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.